Prosight Management Adds $42.7 Million in GeneDx Holdings Shares
On May 15, 2026, Prosight Management disclosed a significant purchase of 468,463 shares in Genomics company GeneDx Holdings (WGS), valued at approximately $42.7 million based on quarterly average pricing. The investment increased the firm's position to about 5.51% of its reportable assets under management.
Tickers: $WGS
Topics: 13F filing GeneDx Holdings stock_purchase